I got an email from a parent of a child who is going progressively blind.

This parent writes to me and says, look, my child is an amazing student and she's doing

so well, but she's going to lose vision.

It's going to happen.

We don't know when.

Can you stop it?

Every day, Dr. Feeder Urnauf's inbox is flooded with emails like that one.

They put him in a difficult position because he has the technology to stop it.

Feodor is a professor at UC Berkeley and a leading researcher in the field of genomic therapies.

He develops medications that change people's DNA to cure genetic diseases like the one

described in that email.

We're not just sitting here hand-drinking, but the fault that's in our stars.

We can actually fly to the stars and touch them and manipulate them.

But having the ability to do something and actually doing it are two very different things.

Medicine has always suffered from a problem called the no-do gap.

It's the difference between what we actually do for our patients and what we could do, given

all that we know.

Breakthroughs and biomedicine are allowing doctors to do things they could never do before.

But sometimes these advances don't fit into our financial or regulatory systems.

That means it can take a long time for patients to actually benefit, time that many of them

don't have to spare.

The National Institutes of Health invests more than $40 billion in biomedical research

...